Xiao-Yan Liu
Overview
Explore the profile of Xiao-Yan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
387
Citations
3053
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Liu S, Zhao Q, Liu X, Liu T, Zhang Q, et al.
World J Hepatol
. 2025 Mar;
17(2):102328.
PMID: 40027566
Non-alcoholic fatty liver disease (NAFLD) is a progressive disease. Without effective interventions, NAFLD can gradually develop to non-alcoholic steatohepatitis, fatty liver fibrosis, liver cirrhosis and even hepatocellular carcinoma. It is...
2.
Li R, Xu W, Liu X, Fu L, Lan Y, Feng S, et al.
Int J Rheum Dis
. 2025 Feb;
28(2):e70156.
PMID: 39995057
Aim: The aim of this study was to construct a predictive model to evaluate the risk of overlapping syndrome (OS), including the combination of systemic sclerosis, rheumatoid arthritis, and Sjögren's...
3.
Sun Y, Xia Y, Zhi Q, Liu X
World J Psychiatry
. 2025 Feb;
15(2):101948.
PMID: 39974483
Background: Phelan-McDermid syndrome (PMS) is a rare genetic disorder characterized by intellectual disability, delayed language development, autism spectrum disorders, motor tone abnormalities, and a high risk of psychiatric symptoms, including...
4.
Chen Y, Qi R, Zhao L, Liang L, Song J, Zhou X, et al.
Int Immunopharmacol
. 2025 Feb;
148:114141.
PMID: 39930646
Doxorubicin (DOX) is a widely used chemotherapy drug for cancer while leads to several cardiac disorders including cardiomyopathy and heart failure. Aprocitentan is a novel dual endothelin-1 receptor antagonist and...
5.
Chang L, Wang L, Liu Z, Lang M, Lin H, Liu X, et al.
Ann Hematol
. 2025 Jan;
104(1):65-74.
PMID: 39774949
Langerhans cell histiocytosis (LCH) is a heterogeneous histiocytosis with various pulmonary manifestations and imaging. We aim to evaluate the pulmonary response of LCH by high resolution chest computed tomography (HRCT)...
6.
Liu Z, Liu X, Tan W, Zhang W, Zhang Y, Zheng L, et al.
Contemp Clin Trials Commun
. 2024 Dec;
42:101409.
PMID: 39735170
Background: Ulcerative colitis (UC) is a chronic non-specific inflammatory intestinal disease, categoried under "dysentery" and "intestinal bleeding" in Traditional Chinese Medicine (TCM). Jianpi Qingchang decoction (JPQC) is a combination formula...
7.
Liu X, Liu Z, Tan W, Zhang W, Zhang Y, Zheng L, et al.
Drug Des Devel Ther
. 2024 Dec;
18:5931-5946.
PMID: 39679131
L. (POL) has a long history of medicinal use worldwide, and numerous clinical and experimental studies demonstrated the therapeutic effects of POL and its active ingredients in the treatment of...
8.
Dai Q, Liu X, Sun F, Ren F
PLoS One
. 2024 Dec;
19(12):e0311441.
PMID: 39652545
Land use in urban agglomerations is the main source of carbon emissions, and reducing them and improving land use efficiency are the keys to achieving sustainable development goals (SDGs). To...
9.
Qi R, Chen Y, Cheng J, Song J, Chen Y, Wang S, et al.
Mol Med
. 2024 Nov;
30(1):223.
PMID: 39567863
Background: Vascular calcification is a crucial pathophysiological process associated with age-related cardiovascular diseases. Elabela, a recently identified peptide, has emerged as a significant player in the regulation of cardiovascular function...
10.
Du Y, Liu X, Pan R, Zhang X, Si X, Chen M, et al.
J Cachexia Sarcopenia Muscle
. 2024 Nov;
15(6):2815-2825.
PMID: 39523982
Background: Cancer cachexia significantly contributes to morbidity and mortality in patients with non-small-cell lung cancer (NSCLC). Inflammatory pathways mediated by interleukin-6 (IL-6) play a crucial role in the development of...